Lipophilin A Inhibitors
Chemical inhibitors of Lipophilin A can affect its function through various mechanisms. Amiloride, for instance, has an inhibitory effect on epithelial sodium channels, which can disrupt the intracellular ion balance, thus impacting Lipophilin A's lipid binding and transport activities. Similarly, Genistein targets tyrosine kinases and by doing so can disrupt the phosphorylation-dependent signaling pathways that may involve Lipophilin A in lipid metabolism. Quinacrine takes a different approach by inhibiting phospholipase A2, potentially reducing the availability of fatty acids and lysophospholipids that are integral for Lipophilin A's lipid-binding function. In the case of Omeprazole, the inhibition of the H+/K+ ATPase can indirectly affect Lipophilin A through alterations in intracellular pH levels, which can influence the protein's structure and lipid interactions.
Chlorpromazine has an effect on lysosomal function and autophagy, which can impinge upon Lipophilin A's role in lipid metabolism within lysosomes. W-7 Hydrochloride, as a calmodulin antagonist, perturbs calcium signaling pathways, which can affect Lipophilin A's calcium-dependent lipid binding or transport. Triacsin C inhibits long-chain acyl-CoA synthetase, thereby potentially reducing the availability of acyl-CoA substrates for lipid biosynthesis, which are substrates Lipophilin A may interact with. Progesterone, by affecting lipid metabolism and transport, can alter the lipid profile and hence Lipophilin A's ability to bind or transport lipids. LY294002, by inhibiting PI3K, affects lipid signaling or transport processes that rely on PI3K activity, which are processes Lipophilin A might be involved in. Tunicamycin and Brefeldin A disrupt Lipophilin A's processing and trafficking by inhibiting N-linked glycosylation and disrupting Golgi apparatus function, respectively. Lastly, GW4869 inhibits neutral sphingomyelinase, which can alter ceramide levels, a lipid that can interact with Lipophilin A, influencing its role in lipid raft maintenance or signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits epithelial sodium channels (ENaC). Since Lipophilin A is involved in lipid transport and homeostasis, inhibiting ENaC can alter intracellular ion balance, potentially impacting Lipophilin A's lipid binding and transport activities. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting tyrosine kinases, it can disrupt phosphorylation-dependent signaling pathways, which could inhibit Lipophilin A's role in cellular signaling related to lipid metabolism. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Quinacrine inhibits phospholipase A2, potentially reducing the availability of fatty acids and lysophospholipids that could be bound by Lipophilin A, thus inhibiting its lipid-binding function. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole inhibits the H+/K+ ATPase in gastric parietal cells. It can indirectly inhibit Lipophilin A by altering intracellular pH levels, which can affect Lipophilin A's structure and its interaction with lipids. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug known to disrupt lysosomal function and autophagy, which could inhibit Lipophilin A's role in lipid metabolism and transport within lysosomes. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 Hydrochloride is a calmodulin antagonist. By inhibiting calmodulin, W-7 can affect calcium signaling pathways, which could inhibit Lipophilin A's function related to calcium-dependent lipid binding or transport. | ||||||
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
Triacsin C inhibits long-chain acyl-CoA synthetase, which could reduce the availability of acyl-CoA substrates for lipid biosynthesis pathways, potentially inhibiting Lipophilin A's lipid-related functions. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone can influence lipid metabolism and transport. By altering the lipid profile, progesterone can inhibit Lipophilin A's ability to bind or transport specific lipids. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K signaling is important for many cellular processes including lipid metabolism. Inhibiting PI3K can inhibit Lipophilin A's role in lipid signaling or transport that relies on PI3K activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation. Since Lipophilin A may undergo glycosylation, inhibiting this process could affect its stability or lipid binding activity, thus functionally inhibiting Lipophilin A. | ||||||